Ravi Viswanathan, 10% Owner at Ra Pharmaceuticals, Inc. (RARX), sold 338,897 shares at $13.00 ($4.4M) on 2016-10-31, disclosed to the SEC on 2016-10-31.
Open-market sale of $4.4M RARX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.00 | 435 | $6K | 0.1% |
| 2 | $13.00 | 338,462 | $4.4M | 99.9% |
| Total | $13.00 avg | 338,897 | $4.4M | 100% |